These cells express surface membrane receptors, with high affinity and specificity for IgE. The interaction of antigenbound IgE in surface membrane receptors causes the release of histamine, prostaglandins, leukotrienes and cytokines. 4, 5) These cytokines activate chemotaxis and phagocytosis of neutrophils and macrophages. Finally, cytokine-induced reactions cause tissue inflammation. These allergic diseases are now rapidly increasing chronic health problem in most countries.
These cytokines activate chemotaxis and phagocytosis of neutrophils and macrophages. Finally, cytokine-induced reactions cause tissue inflammation. These allergic diseases are now rapidly increasing chronic health problem in most countries. 6) Antiallergic agents, such as anti-histamines, steroids and immunosuppressants, have been used against allergic diseases, such as allergic rhinitis, atopic dermatitis, asthma and food allergies, [7] [8] [9] but improving these diseases is very difficult. Therefore, herbal medicines have been advanced for allergic diseases, and their effectiveness has received increasing attention. 10, 11) The fruit of Schizandra chinensis BAILL (SZ, Family Magnoliaceae) has frequently been used as a tonic and astringent agent in traditional Korean, Chinese and Japanese medicines. SZ, which contains lignans, such as schizandrin and gomisin A, as main constituents, has been reported to have many biological properties, including hepatoprotective, anti-inflammatory and antitumor activites. [12] [13] [14] [15] In preliminary experiments, SZ was found to inhibit the mouse passive cutaneous anaphylaxis reaction induced by the antigen-IgE complex. However, the antiallergic effect of these components remains to be thoroughly studied.
Therefore, to evaluate the antiallergic activity of SZ, a main constituent, schizandrin, was isolated from the fruit of SZ and its in vivo inhibitory activity against scratching behaviors and passive cutaneous anaphylaxis (PCA) investigated. (Fig. 1) was isolated from the fruits of SZ, according to the previous reports. 16, 17) Animals The male ICR mice (20-25 g ) and male Sprague-Dawley rats were supplied by the Orient Experimental Animal Breeding Center (Seoul, Korea). All animals were housed in wire cages at 20-22°C and 50Ϯ10% humidity, fed standard laboratory chow (Orient Experimental Animal Breeding Center, Seoul, Korea) and allowed water ad libitum. All procedures relating to the animals and their care conformed to the international guidelines 'Principles of Laboratory Animals Care' (NIH publication no. 85-23, revised 1985) .
MATERIALS AND METHODS

Materials
Measurement of PCA Reaction An IgE-dependent cutaneous reaction was measured according to the previous method of Choo et al. 18) The male ICR mice were intradermally injected, with 10 mg of anti-DNP IgE, into each of two dorsal skin sites that had been shaved 48 h earlier. The sites were outlined with a water-insoluble red marker. Forty-eight hours later each mouse received an injection of 200 ml of 3% Evans blue in PBS, containing 200 mg of DNP-HAS, via the tail vein. The test agents were orally or intraperitoneally administered 1 h prior to the DNP-HSA injection. Thirty minutes after the DNP-HSA injection, the mice were sacrificed, 19) The rostral part of the skin on the back of the mice was clipped, and 50 mg/50 ml of compound 48/80 (dissolved in saline) intradermally injected into each mouse. Control mice received a saline injection in the place of the compound 48/80. Immediately after the intradermal injection, the mice (one animal/cage) were put back into the same cage and the scratching behaviors recorded using an 8-mm video camera (SV-K80, Samsung, Seoul, Korea) under unmanned conditions. Scratching of the injected site with the hind paws was counted and compared with that of other sites, such as the ears. Each mouse was used for only one experiment. The mice generally showed several scratches per second, and a series of these behaviors was counted as one incident of scratching over a 60 min period. The test agents were orally administered 1 h before the scratching agent.
Assay of Serum IgE in Mouse Asthmic Mice Induced by OVA The BALB/c mice were sensitized using an intraperitoneal injection of 1 ml of a mixture of 0.005% OVA and 1ml aluminum hydroxide gel (alum, Rehydragel; Reheis, Berkeley Heights, NJ, U.S.A.). The non-sensitized mice received an intraperitoneal injection of alum alone. On the 10th day, the mice were given an intraperitoneal booster injection of the same antigen or alum. On the 17th day after sensitization, the mice were challenged with aerosolized 5% OVA, which was generated using an ultrasonic nebulizer (UltraNeb 99; DeVilbiss, Somerset, PA, U.S.A.). The aerosol was circulated through a large acrylic cylindrical chamber, with mice then placed in the chamber for 1 h per day. The OVA aerosol challenge was repeated for 5 d. Test agents [50 mg/kg (schizandrin) or 10 mg/kg (betamethasone)] were orally administered 1 h prior to the 5 d OVA aerosol challenge. On the next day, the mice were sacrificed and the level of IgE in the blood measured according to the previously reported method.
20)
Enzyme-Linked Immunosorbent Assay (ELISA) of IL-4 ad TNF-a a in RBL-2H3 Cells Stimulated by IgE-Antigen Complex RBL-2H3 cells (5ϫ10 5 cells), previously cultured in DMEM, were treated with 0.5 mg/ml of mouse monoclonal IgE to sensitize the cells. The cells (1.8 ml) were exposed to 0.2 ml of the test agents (dissolved in 0.5% dimethyl sulfoxide) for 4 h, followed by treatment with 0.2 ml DNP-HSA (1 mg/ml) for 40 min at 37°C. The supernatant (50 ml) was transferred to 96-well ELISA plates, and the IL-4 ad TNF-a concentrations then determined using commercial ELISA Kits (Pierce Biotechnology, Inc., Rockford, IL, U.S.A.).
21)
Assay of Degranulation of RBL-2H3 Cells and Rat Peritoneal Mast Cells Stimulated by IgE-Antigen Complex
The inhibitory activity of test agents against the release of b-hexosaminidase from RBL-2H3 cells and histamine of rat peritoneal mast cells was evaluated according to Choo et al.
18)
Statistical Analysis All data were expressed as the mean Ϯstandard deviation, with statistical significance analyzed using one-way ANOVA followed by a Student-NewmanKeuls test.
RESULTS AND DISCUSSION
During the screening program to evaluate the antiallergic activity of herbal medicines, SZ was found to inhibit the mouse PCA reaction induced by IgE-antigen complex. Therefore, a main constituent, schizandrin, from SZ was isolated, and its PCA reaction-inhibitory effect in mice measured ( Table 1 ). The PCA reaction was induced by an injection of IgE and antigen, with schizandrin administered orally 1 h prior to the challenge with antigen. The IgE-antigen complex potently induced the PCA reaction. Schizandrin showed potent inhibition against the PCA reaction. Schizandrin also inhibited the scratching behavior induced by compound 48/80. Schizandrin, at doses of 10 and 50 mg/kg, reduced the scratching behavior frequency by 7 and 45%, respectively. The effect of schizandrin on the serum IgE production in asthmic mice induced by OVA was also measured. Schizandrin was found to inhibit the serum IgE concentration by 30%. Nevertheless, its inhibitory effect was weak compared with that of betamethasone.
To understand the antiallergic mechanism of schizandrin, its degranulation-inhibitory activities against rat peritoneal mast cells and RBL-2H3 cells were measured (Fig. 2) . Schizandrin inhibited the degranulation of rat peritoneal mast cells induced by compound 48/80 and RBL-2H3 cells induced by the IgE-antigen complex; its IC 50 values were 97 and 95 mM, respectively, and those of azelastine were 32 and 26 mM, respectively. When the inhibitory effect of schizandrin on the protein expressions of proinflammatory cytokines, TNF-a and IL-4, in RBL-2H3 cells induced by IgE-antigen complex was measured using an ELISA assay, a concentration of 50 mM was found to inhibit the expressions of TNF-a and IL-4 by 42 and 37%, respectively (Fig. 3) .
Azelastine, a representative antiallergic drug, 22) is an H1-receptor antagonist, which decreases the mediator release 
a) The amounts of extravasated Evan blue from the dorsal skin (1ϫ1 cm) of the control stimulated with the IgE-antigen complex and vehicle-treated groups were 25Ϯ3 and 11Ϯ2 mg, respectively. b) Scratching behavior number frequency of the normal control, which was treated with saline alone, and the control group, which was treated with compound 48/80 and saline, for 1 h were 239Ϯ25 and 3Ϯ1, respectively. c) The mice were sensitized by an intraperitoneal injection of 5 mg ovalbumin (OVA) mixed with alum, given an intraperitoneal booster injection of the same antigen and then challenged with aerosolized 5% OVA. Test agents were orally administered 1 h prior to the 5 day OVA aerosol challenge. The mice were sacrificed, and the level of IgE in the blood measured using an ELISA kit. The amounts of blood IgE in the control stimulated with ovalbumin and vehicle-treated groups were 71Ϯ5.1 and 10.5Ϯ2.1 ng/ml, respectively. from mast cells and basophils. Quercetin, a non-steroidal anti-inflammatory flavonoid, scavenges superoxide anion and inhibits the PCA reaction. 23) SZ has been reported to exhibit hepatoprotective and antiinflammatory effects. In the present study, schizandrin, isolated from SZ, was found to inhibit the mouse PCA reaction. Schizandrin also inhibited the scratching behavior induced by compound 48/80 and the production of IgE in OVAinduced asthmic mice. However, schizandrin, at 10 mg/kg, weakly inhibited the PCA reaction, although showed potent inhibition against scratching behaviors. Generally, scratching behaviors are caused by the pruritogens (amines, proteases and cytokines), which express biological actions at more than the threshold dose. For schizandrin to inhibit scratching behaviors, it may overcome the dose that inhibits the itching action of pruritogen. Therefore, the inhibitory mode of schizandrin against scratching behaviors may be different from that against the PCA reaction. Xu et al. 24) reported the absolute bioavailability of schizandrin to be 14.8% in rats when orally administered (10 mg/kg), with its maximal concentration in blood occurred at 0.5 h after its oral administration. These results suggest that orally administered schizandrin can be quickly absorbed into the blood, and may then express its pharmacological effects, such as hepatoprotective and antiallergic activities, within 1 h of oral administration.
From our in vitro study, schizandrin was also found to inhibit the degranulation of rat peritoneal mast cells and RBL-2H3 cells induced by compound 48/80 and by the IgE-antigen complex, respectively. However, gomisins C, N and G, schisandrol B and schizandrin C, isolated from SZ, at the concentration of more than 100 mM did not inhibit the degranulation of these cells by 2, 5, 2, 12 and 19%, respectively (data not shown). This result suggest that the methylenedioxyl group in dibenzocyclooctadiene-type lignans isolated from SZ may reduce the inhibitory activity against the degranulation of mast cells, but hydroxyl group may increase it. Schizandrin also inhibited the protein expressions of some cytokines, TNF-a and IL-4, in RBL-2H3 cells as well as the mRNA expressions (data not shown). The previous investigations have reported that derivatives of schizandrin, such as gomisin A and schizandrin A, isolated from SZ, potently inhibited NF-kB activation and exhibited anti-inflammatory and PAF-antagonic effects. 17, 25) These results suggest that schizandrin may inhibit NF-kB activation in RBL-2H3 cells.
Based on these findings, the inhibitory effect of schizandrin against the PCA reaction and scratching behaviors may be due to the inhibition of mast cell degranulation and cytokine expressions of TNF-a and IL-4. Nevertheless, the anti-PCA reaction and anti-scratching behavior mechanisms of schizandrin can not be sufficiently established. Therefore, its inhibitory mechanisms remain to be solved.
Finally, these findings suggest that schizandrin may improve the IgE-induced anaphylaxis and scratching behaviors. The peritoneal exudate cells (5ϫ10 4 /ml) were isolated from male Wister rats (200Ϯ20 g) were injected intraperitoneally with 20 ml of physiological solution, washed and pooled. The cell suspension (2.5 ml) was mixed with various concentrations of schizandrin and azelastine in 0.5 ml of each physiological solution, and preincubated at 37°C for 5 min. The control and blank were treated in the same manner. The degranulation-inhibitory activities of the test agents against rat peritoneal mast cells stimulated by compound 48/80 were evaluated according to the method of Choo et al. 18) RBL-2H3 cells, which were grown in DMEM supplemented with 10% fetal bovine serum and L-glutamine, were dispensed into 24 well plates, at a concentration of 5ϫ10 5 cells per well, and sensitized using 0.5 mg/ml of mouse monoclonal IgE. They were then washed with 500 ml of siraganian buffer, exposed to test agents for 20 min, and treated with 20 ml of antigen (DNP-HSA, 1 mg/ml) for 10 min at 37°C. The release of b-hexosaminidase from RBL-2H3 cells was measured according to the method of Choo et al. 18) The concentrations of test agents were follows: open bar, 10 mM; dotted bar, 50 mM; closed bar, 100 mM). 
